Viewing StudyNCT00125970



Ignite Creation Date: 2024-05-05 @ 11:46 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00125970
Status: COMPLETED
Last Update Posted: 2021-10-15
First Post: 2005-06-30

Brief Title: HVTN Protocol 204 - A Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine VRC-HIVDNA016-00-VP Followed by a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Boost VRCHIVADV014-00-VP in HIV-1 Uninfected Adult Participants
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-09
Start Date Type: None
Primary Completion Date: 2008-02
Primary Completion Date Type: ACTUAL
Completion Date: 2010-01
Completion Date Type: ACTUAL
First Submit Date: 2005-06-30
First Submit QC Date: August 1 2005
Study First Post Date: 2005-08-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2010-01-30
Disp First Submit QC Date: January 30 2010
Disp First Post Date: 2010-02-02
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2021-10-13
Last Update Post Date: 2021-10-15
Last Update Post Date Type: ACTUAL